DeNovo Malignancy after Liver Transplantation in Patients With and Without Hepatocellular Carcinoma

Authors

Mohammad Abuassi, HCA HealthcareFollow
Carson Creamer, HCA HealthcareFollow
Harsimran Kalsi, HCA HealthcareFollow
Kobina Essilfie-Quaye, HCA HealthcareFollow
Tony S. Brar
Yaseen Perbtani, HCA HealthcareFollow

Files

Division

North Florida

Hospital

HCA Florida North Florida Hospital

Specialty

Internal Medicine

Document Type

Poster

Publication Date

2025

Keywords

Hepatocellular Carcinoma, DeNovo Malignancy

Disciplines

Internal Medicine | Medicine and Health Sciences | Neoplasms | Surgical Procedures, Operative

Original Publisher

HCA Healthcare Graduate Medical Education

Comments

NFL Research Day

Recommended Citation

Abuassi, Mohammad; Creamer, Carson; Kalsi, Harsimran; Essilfie-Quaye, Kobina; Brar, Tony S.; and Perbtani, Yaseen, "DeNovo Malignancy after Liver Transplantation in Patients With and Without Hepatocellular Carcinoma" (2025). North Florida Division GME Research Day 2025. 21.
https://scholarlycommons.hcahealthcare.com/northflorida2025/21